Open Payments

DALE R LUCUS

Type
Physician · Allopathic & Osteopathic Physicians / Family Medicine
Where
CLEBURNE, TX
NPI
1063494979
Received
$192,338 in 87 records, 2020 to 2025
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment23$53,333
2024General payment24$55,000
2023General payment9$20,400
2022General payment12$26,600
2021General payment11$23,833
2020General payment8$13,171

By company

CompanyRecordsAmountYears
Takeda Pharmaceuticals U.S.A., Inc.87$192,3382020–2025

By nature of payment

NatureRecordsAmount
Consulting Fee86$192,275
Travel and Lodging1$63

Records

DateCompanyAmountNatureFormProductStudyYear
2025-12-05Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-11-12Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-11-12Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-10-08Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-10-08Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-09-10Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-09-10Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-08-08Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-08-08Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-07-11Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-07-11Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-06-11Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-06-11Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-05-09Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-05-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-04-11Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-04-11Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-03-12Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-03-12Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-02-12Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-02-12Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2025-01-17Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2025
2025-01-17Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2025
2024-12-09Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2024
2024-12-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-11-13Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2024
2024-11-13Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-10-09Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2024
2024-10-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-09-11Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2024
2024-09-11Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-08-09Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2024
2024-08-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-07-12Takeda Pharmaceuticals U.S.A., Inc.$2,366Consulting FeeCash or cash equivalent2024
2024-07-12Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-06-10Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-06-10Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-05-10Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-05-10Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-04-17Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-04-17Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-03-11Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-03-11Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-02-14Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-02-14Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-01-17Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2024-01-17Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2024
2023-12-15Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-12-15Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-11-10Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-10-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-09-13Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-07-14Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-06-14Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-04-07Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2023-02-08Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2023
2022-12-07Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2022
2022-11-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2022
2022-10-05Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2022
2022-09-09Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2022
2022-08-17Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2022
2022-07-13Takeda Pharmaceuticals U.S.A., Inc.$2,266Consulting FeeCash or cash equivalent2022
2022-06-06Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2022
2022-05-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2022
2022-04-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2022
2022-03-08Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2022
2022-02-07Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2022
2022-01-11Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2022
2021-12-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-11-06Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-10-11Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-09-13Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-08-10Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-07-15Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-06-10Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-05-11Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-04-12Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-03-08Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2021-02-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2021
2020-12-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2020
2020-11-10Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2020
2020-10-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2020
2020-09-18Takeda Pharmaceuticals U.S.A., Inc.$1,800Consulting FeeCash or cash equivalent2020
2020-09-18Takeda Pharmaceuticals U.S.A., Inc.$63Travel and LodgingIn-kind items and services2020
2020-09-09Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2020
2020-08-11Takeda Pharmaceuticals U.S.A., Inc.$2,166Consulting FeeCash or cash equivalent2020
2020-07-13Takeda Pharmaceuticals U.S.A., Inc.$475Consulting FeeCash or cash equivalent2020

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Johnson CountyCleburne city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Cleburne, TX, county Johnson County, TX, state Texas; placed by its city name.

MeasurePlace (city or town)
Cleburne, TX
County
Johnson County, TX
State
Texas
Population B0100334,344195,59730,188,424
Population, 2020 census P131,352179,92729,145,505
Median age B0100235.037.135.6
Under 18 B0100126.5%25.7%25.0%
65 and over B0100114.6%14.0%13.4%
Households B1100111,51965,50710,992,816
Foreign born B050027.4%6.9%17.6%
Median household income B19013$70,656$84,859$78,476
Median family income B19113$79,757$94,954$94,599
Per capita income B19301$32,059$35,637$40,752
Poverty rate B1700110.0%10.0%13.8%
Unemployment rate B230252.0%3.6%5.3%
Civilian labor force B2302516,38496,73615,233,563
Mean commute (minutes) B0801325.431.726.7
Bachelor's degree or higher B1500320.3%25.2%33.8%
Housing units B2500112,46770,79612,128,515
Owner-occupied B2500360.4%74.7%62.6%
Renters B2500339.6%25.3%37.4%
Median home value B25077$221,100$285,900$283,800
Median gross rent B25064$1,322$1,398$1,403
White, not Hispanic B0300255.1%64.6%39.1%
Black B030026.0%5.1%11.9%
Hispanic or Latino B0300232.2%25.3%39.7%
Asian B030020.8%1.1%5.5%
American Indian and Alaska Native B030020.1%0.2%0.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Cleburne, TX.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.